TABLE 1

Demographics and clinical presentation in patients with COVID-19 pneumonia

CharacteristicsTotalDeceasedSurvivorsp-value
Patients17921158
Age years57.6±13.770.2±7.756.0±13.5<0.001
Sex0.642
 Male97 (54.2)10 (47.6)87 (55.1)
 Female82 (45.8)11 (52.4)71 (44.9)
Underlying diseases
 Hypertension58 (32.4)13 (61.9)45 (28.5)0.005
 Cardiovascular or cerebrovascular diseases29 (16.2)12 (57.1)17 (10.8)<0.001
 Diabetes33 (18.4)6 (28.6)27 (17.1)0.231
 Chronic digestive disorders21 (11.7)4 (19.0)17 (10.8)0.279
 Tuberculosis8 (4.5)0 (0)8 (5.1)0.599
 Chronic hepatic or renal insufficiency4 (2.2)2 (9.5)2 (1.3)0.068
 Peripheral vascular disease4 (2.2)2 (9.5)2 (1.3)0.068
 Malignancy4 (2.2)1 (4.8)3 (1.9)0.396
Symptoms
 Fever177 (98.9)21 (100)156 (98.7)1.000
 Dry cough146 (81.6)14 (66.7)132 (83.5)0.074
 Dyspnoea89 (49.7)18 (85.7)71 (44.9)<0.001
 Fatigue71 (39.7)13 (61.9)58 (36.7)0.033
 Sputum production55 (30.7)12 (57.1)43 (27.2)0.010
 Gastrointestinal symptoms39 (21.8)8 (38.1)31 (19.6)0.087
 Myalgia34 (19.0)7 (33.3)27 (17.1)0.083
 Headache17 (9.5)5 (23.8)12 (7.6)0.033
 Haemoptysis10 (5.6)0 (0)10 (6.3)0.609
Systolic blood pressure mmHgNA122.4±18.6
Diastolic blood pressure mmHgNA77.9±10.0
Temperature °C0.156
 <37.3109 (60.9)16 (76.2)93 (58.9)
 ≥37.370 (39.1)5 (23.8)65 (41.1)
Respiratory rate breaths·min−120.0 (20.0–21.0)20.0 (20.0–34.5)20.0 (20.0–21.0)0.016
Heart rate beats·min−186.0 (78.0–100)94.0 (78.0–109.5)85.5 (78.0–99.3)0.150

Data are presented as n, mean±sd, n (%) or median (interquartile range), unless otherwise stated. NA: not available.